- Zacks•1 hour ago
This week's highlights include rumors regarding Sanofi (SNY) acquiring Flexion, accelerated FDA approval for a Pfizer/Merck KGaA drug and drug pricing.
- Investor's Business Daily•15 hours ago
Flexion Therapeutics stock rocketed to an 18-month high Thursday on rumors that it accepted a $1 billion offer from French drugmaker Sanofi put in a $1 billion bid to acquire it.
- Motley Fool•17 hours ago
Shares shot up 33% on Thursday, fueled by rumors that the company is about to accept a takeover bid.
SAN.PA : Summary for SANOFI - Yahoo Finance
Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
|Bid||71.12 x 1000|
|Ask||71.74 x 44000|
|Day's Range||82.42 - 83.11|
|52 Week Range||62.50 - 83.86|
|PE Ratio (TTM)||22.79|
|Dividend & Yield||3.35 (3.75%)|
|1y Target Est||N/A|